An Epigenetic Locus Associated with Loss of Smell in COVID-19
Open Access
- 15 December 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (24) , 2823
Abstract
Background/Aim: Loss of smell, also known as anosmia, is a prevalent and often prolonged symptom following infection with SARS-CoV-2. While many patients regain olfactory function within weeks, a significant portion experience persistent anosmia lasting over a year post-infection. The underlying mechanisms responsible for this sensory deficit remain largely uncharacterized. Previous studies, including genome-wide association studies (GWAS), have identified genetic variants near the UGT2A1 and UGT2A2 genes that are linked to anosmia in COVID-19 patients. However, the role of epigenetic changes in the development and persistence of smell loss has not been well explored. In this study, we aimed to investigate epigenetic alterations in the form of DNA methylation in the UGT1A1 gene, which is a locus associated with olfactory dysfunction in COVID-19 patients. Methods: We analysed DNA methylation patterns in blood samples from two carefully matched cohorts of 20 COVID-19 patients each, which are differentiated by their olfactory function—those with normal smell (normosmia) and those suffering from smell loss (anosmia). The cohorts were matched for age and sex to minimize potential confounding factors. Results: Using quantitative analysis, we found significantly lower levels of DNA methylation in the UGT1A1 locus in the anosmia group compared to the normosmia group, with a 14% decrease in median methylation values in patients with smell loss (p < 0.0001). These findings highlight potential epigenomic alterations in the UGT1A1 gene that may contribute to the pathogenesis of anosmia following COVID-19 infection. Our results suggest that the methylation status at this locus could serve as a biomarker for olfactory dysfunction in affected individuals. Conclusion: This study is among the first to describe epigenetic changes associated with smell loss in COVID-19, providing a foundation for future research into targeted interventions and potential therapeutic strategies aimed at reversing persistent anosmia. Further investigations involving larger cohorts and additional loci may help elucidate the complex interaction between genetic, epigenetic, and environmental factors influencing long-term sensory impairment post-COVID-19.Keywords
Funding Information
- Biruni University Scientific Research Coordination Unit (BIRATTO) (Biruni-BAP-2020-01-09)
This publication has 24 references indexed in Scilit:
- Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infectionMolecular Biology Reports, 2024
- Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept studyActa Neuropathologica, 2022
- Olfactory dysfunction as a post-infectious symptom of SARS-CoV-2 infectionAnnals of Medicine & Surgery, 2022
- The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or tasteNature Genetics, 2022
- Post-traumatic olfactory loss and brain response beyond olfactory cortexScientific Reports, 2021
- Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19Journal of Leukocyte Biology, 2021
- The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical PracticeThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Epigenome-wide association studies for common human diseasesNature Reviews Genetics, 2011
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005
- Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholdsEuropean Archives of Oto-Rhino-Laryngology, 2000